Fuji launches pricing models
Marketing execs at Fujifilm Medical Systems USA have revamped the company's pricing models for PACS in hopes of extending the reach of Synapse. Fuji's new volume-based site license model considers procedure volume and planned concurrency of use, allowing
Marketing execs at Fujifilm Medical Systems USA have revamped the company's pricing models for PACS in hopes of extending the reach of Synapse. Fuji's new volume-based site license model considers procedure volume and planned concurrency of use, allowing customers unlimited use of the Synapse application, regardless of the number of servers, workstations, and modalities that may be in use. Children's Hospital in Boston has already taken advantage of the pricing scheme to make Synapse available on more than 3000 desktops.
A different Fuji program has been designed to meet the needs of smaller facilities conducting fewer than 45,000 radiological studies per year. The turnkey solution, dubbed the Single Step to Digital program, offers three individual purchase packages combining Synapse, Fuji Computed Radiography, and Fuji DryPix imagers. Options include the purchase of just Synapse, Synapse with Fuji's XG5000 and DryPix 5000, or Synapse with the SmartCR and DryPix 3000.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
